257 related articles for article (PubMed ID: 16085167)
1. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
Hillard PJ
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
[TBL] [Abstract][Full Text] [Related]
2. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
3. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
[TBL] [Abstract][Full Text] [Related]
4. Syndromes of hyperandrogenism in women.
Davis S
Aust Fam Physician; 1999 May; 28(5):447-51. PubMed ID: 10376368
[TBL] [Abstract][Full Text] [Related]
5. Adolescent polycystic ovary syndrome.
Connor EL
Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome.
Kahn JA; Gordon CM
Adolesc Med; 1999 Jun; 10(2):321-36. PubMed ID: 10370713
[TBL] [Abstract][Full Text] [Related]
7. Treatment of PCOS in adolescence.
Warren-Ulanch J; Arslanian S
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):311-30. PubMed ID: 16772160
[TBL] [Abstract][Full Text] [Related]
8. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
9. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
Szpringer EA; Lutnicki KR; Zych IS
Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
[TBL] [Abstract][Full Text] [Related]
10. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
11. Use of insulin sensitizers in polycystic ovarian syndrome.
Baillargeon JP
Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
[TBL] [Abstract][Full Text] [Related]
12. ACOG releases guidelines on diagnosis and management of polycystic ovary syndrome.
Schroeder BM;
Am Fam Physician; 2003 Apr; 67(7):1619-20, 1622. PubMed ID: 12722867
[No Abstract] [Full Text] [Related]
13. Secondary forms of polycystic ovary syndrome.
Kaltsas GA; Isidori AM; Besser GM; Grossman AB
Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovarian syndrome in adolescents.
Creatsas G; Deligeoroglou E
Curr Opin Obstet Gynecol; 2007 Oct; 19(5):420-6. PubMed ID: 17885456
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
16. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome.
Soares GM; Vieira CS; de Paula Martins W; Dos Reis RM; de Sá MF; Ferriani RA
Int J Clin Pract; 2009 Jan; 63(1):160-9. PubMed ID: 18795969
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.
Schroeder B
Curr Womens Health Rep; 2001 Oct; 1(2):124-30. PubMed ID: 12112959
[TBL] [Abstract][Full Text] [Related]
19. Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.
Garmes HM; Tambascia MA; Zantut-Wittmann DE
Gynecol Endocrinol; 2005 Dec; 21(6):317-23. PubMed ID: 16390779
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives in polycystic ovary syndrome.
Helvaci N; Yildiz BO
Minerva Endocrinol; 2014 Sep; 39(3):175-87. PubMed ID: 25003228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
